Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus

Hepatology Research

Volumn 35, Issue 2, 2006, Pages 135-139

  Masaki, Naohiko ^a   Imamura, Masatoshi ^a   Kikuchi, Yoshimi ^a   Oka, Shinichi ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

HCV; HIV; Liver fibrosis; Stiffness

Indexed keywords

COLLAGEN TYPE 4; HYALURONIC ACID; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; ARTICLE; BLEEDING TENDENCY; CHRONIC LIVER DISEASE; CHRONICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ELASTOMETRY; FATTY LIVER; FEMALE; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEIN DOMAIN; RIGIDITY; STATISTICAL SIGNIFICANCE; SUPERINFECTION; THROMBOCYTE COUNT;

EID: 33646820689     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2006.02.006     Document Type: Article

References (11)

1. Di Martino V., Rufat P., Boyer N., et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34 (2001) 1193-1199
2. Sandrin L., Fourquet B., Hasquenoph J.M., et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003) 1705-1713
3. Castera L., Vergniol J., Foucher J., et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128 (2005) 343-350
4. Saito H., Tada S., Nakamoto N., et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 29 (2004) 97-103
5. Adinolfi L.E., Giordano M.G., Andreana A., et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol 113 (2001) 590-595
6. Darby S.C., Ewart D.W., Giangrande P.L., et al. Mortality from liver cancer and liver disease in haemophiliac men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation. Lancet 350 (1997) 1425-1431
7. Kramer J.R., Giordano T.P., Souchek J., et al. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol 100 (2005) 56-63
8. Marine-Barjoan E., Saint-Paul M.C., Pradier C., et al. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS 18 (2004) 2163-2170
9. Martinez-Sierra C., Arizcorreta A., Diaz F., et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus. Clin Infect Dis 36 (2003) 491-498
10. Macias J., Castellano V., Merchante N., et al. Effect of anriretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine. AIDS 18 (2004) 767-774
11. Aranzabal L., Casado J.L., Moya J., et al. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 40 (2005) 588-593